1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Kidney conditions
  5. Chronic kidney disease

Irbesartan–propagermanium for treating focal segmental glomerulosclerosis in people 12 years and over having an angiotensin II receptor blocker ID 6469

Awaiting development [GID-TA11575] Expected publication date: TBC

  • Project information
  • Project documents

26875-DMX-200-for-Focal-Segmental-Glomerulosclerosis-V1.0-JAN2024-NON-CONF.pdf (nihr.ac.uk)